Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Debin Sun
Observed name:
Sun, Debin
Institution:
Lishui Central Hospital
Observed institutions:
Shanghai Jiao Tong University,
Wenzhou Medical University,
Lishui Central Hospital,
Shanghai Sixth People's Hospital,
Genecast (China)
OpenAlex ID:
A5101118484
EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma
2022
·
Shengjin Dou
, Lin Zhang
, et al.
·
Frontiers in Immunology
·
28
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
2021
·
Yuankai Shi
, Kaijian Lei
, et al.
·
癌症:英文版
·
27
Insulin‐like growth factor binding protein‐4 inhibits cell growth, migration and invasion, and downregulates COX‐2 expression in A549 lung cancer cells
2017
·
Weiwen Li
, Debin Sun
, et al.
·
Cell Biology International
·
26
Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers
2024
·
Jiahao Zhang
, Yiheng Huang
, et al.
·
npj Precision Oncology
·
17
PDF
RETRACTED: Physcion 8‐O‐β‐Glucopyranoside Exerts Anti‐Tumor Activity Against Non‐Small Cell Lung Cancer by Targeting PPARγ
2018
·
Youyi Du
, Zhuqing Lv
, et al.
·
The Anatomical Record
·
13
PDF
Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Wenqi Xi
, Chenfei Zhou
, et al.
·
Journal of Translational Medicine
·
12
PDF
Immune‐related lncRNA signature delineates an immune‐excluded subtype of liver cancer with unfavorable clinical outcomes
2022
·
Yawei Chen
, Leying Xi
, et al.
·
Journal of Clinical Laboratory Analysis
·
6
Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma
2021
·
Wenbo Guo
, Jilin Lu
, et al.
·
Journal of Oncology
·
5
PDF
Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics
2024
·
Wei Guo
, Tong Lu
, et al.
·
Cancer Medicine
·
3
Surface EMG observation and isokinetic test on pressing-kneading manipulations for exercise fatigue of anterior tibial muscle
2011
·
Junfeng Zhang
, Debin Sun
·
Journal of Acupuncture and Tuina Science
·
3
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study
2025
·
Wen Jiang
, Shengjin Dou
, et al.
·
Frontiers in Immunology
·
2
PDF
The effective molecular characteristics of PD-1 inhibitor combination regimen as the first-line treatment for Chinese patients with HER2-positive gastric cancer: a real-world retrospective analysis study
2025
·
Lingyun Zhang
, Bin Guan
, et al.
·
Translational Gastroenterology and Hepatology
·
2
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
2024
·
Ying Cheng
, Zhanyu Pan
, et al.
·
Advances in Therapy
·
2
Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report
2022
·
Xiangming Cao
, Xiongwei Liu
, et al.
·
Journal of International Medical Research
·
1
Novel biomarkers for head and neck squamous cell carcinoma: A retrospective study.
2021
·
Shengjin Dou
, Lin Zhang
, et al.
·
Journal of Clinical Oncology
·
1
Correlation of STAT3, CEA in lung adenocarcinoma cell A549
2012
·
Debin Sun
, Xiu Lan
, et al.
·
The Chinese-German Journal of Clinical Oncology
·
1
Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study
2026
·
Jia Yu
, Anwen Xiong
, et al.
·
Signal Transduction and Targeted Therapy
PDF
Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
2024
·
Yiyi Yu
, Zhening Zhang
, et al.
·
Clinical and Translational Discovery
PDF
Cover Image
2024
·
Wei Guo
, Tong Lu
, et al.
·
Cancer Medicine
PDF
Efficacy of Pembrolizumab as Treatment Beyond Failure of First-Line Treatment in Stage IV Non-Small Cell Lung Cancer: A Real-World Study
2023
·
Kexin Ruan
, Xiaodong Lv
, et al.
·
SSRN Electronic Journal
Additional file 12 of Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Xi, Wenqi
, Zhou, Chenfei
, et al.
·
Figshare
Additional file 10 of Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Xi, Wenqi
, Zhou, Chenfei
, et al.
·
Figshare
Additional file 9 of Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Xi, Wenqi
, Zhou, Chenfei
, et al.
·
Figshare
Additional file 14 of Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Xi, Wenqi
, Zhou, Chenfei
, et al.
·
Figshare
Additional file 13 of Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA
2022
·
Xi, Wenqi
, Zhou, Chenfei
, et al.
·
Figshare
Show more works
View as search
Works count:
32
Citation count:
149
H-index:
6
I10-index:
6
Year
Topic
Type